U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07602699) titled 'Multi-Site Trial of Tirzepatide for Smoking Cessation' on May 11.
Brief Summary: This multi-site clinical trial will generate data on the efficacy of tirzepatide for smoking cessation and associated outcomes (e.g., post-cessation weight gain) in treatment-seeking people who smoke (PWS) with overweight or obesity. A sample of 300 treatment-seeking people who smoke with body mass index of 25 kg/m2 or greater will be recruited from four geographic sites (University of Southern California, Yale University, University of Chicago, and University of Colorado Anschutz Medical Campus) to participate in a parallel-arm, dose-escalating, placebo...